Soluble human MHC class I molecules induce soluble Fas ligand secretion and trigger apoptosis in activated CD8+ Fas (CD95)+ T lymphocytes

International Immunology

Volumn 12, Issue 2, 2000, Pages 195-203

  Puppo, Francesco ^a   Contini, Paola ^a   Ghio, Massimo ^a   Brenci, Sabrina ^a   Scudeletti, Marco ^a   Filaci, Gilberto ^a   Ferrone, Soldano ^b   Indiveri, Francesco ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

HLA; Immunomodulation

Indexed keywords

CD8 ANTIGEN; FAS LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PHYTOHEMAGGLUTININ;

ANTIGEN BINDING; APOPTOSIS; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MONOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0033953078     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/12.2.195     Document Type: Article

References (68)

1. Natali, P. G., Bigotti, A., Nicotra, M. R., Viora, M., Manfredi, D. and Ferrone, S. 1984. Distribution of human class I (HLA-A,B,C) histocompatibility antigens in normal and malignant tissues of nonlymphoid origin. Cancer Res. 44:4679.
2. Van Rood, J. J., van Leeuwen, A and van Santen, M. C. T. 1970. Anti HL-A2 inhibitor in normal human serum. Nature 226:366.
3. Charlton, R. K. and Zmijewski, C. M. 1970. Soluble HL-A7 antigen: localization in the β-lipoprotein fraction of human serum. Science 170:636.
4. Allison, J. P., Pellegrino, M. A., Ferrone, S., Callahan, G. N. and Reisfeld, R. A. 1977. Biologic and chemical characterization of HLA antigens in human serum. J. Immunol. 118:1004.
5. 2-microglobulin free HLA class I α chains. J. Immunol. 151:2613.
6. 2-m associated HLA class I heavy chain levels and HLA phenotype. Tissue Antigens 53:253.
7. Puppo, F., Scudeletti, M., Indiveri, F. and Ferrone, S. 1995. Serum HLA class I antigens: markers and modulators of an immune response? Immunol. Today 16:124.
8. Puppo, F., Brenci, S., Lanza, L., Bosco, O., Imro, M. A., Scudeletti, M., Indiveri, F. and Ferrone, S. 1994, Increased level of serum HLA class I antigens in HIV infection. Correlation with disease progression. Hum. Immunol. 40:259.
9. Puppo, F., Indiveri, F., Scudeletti, M. and Ferrone, S, 1997, Soluble HLA antigens: new roles and uses, Immunol. Today 18:154.
10. Van Rood, J. J., van Leeuwen, A., Koch, C. T. and Frederiks, E. 1970. HLA inhibiting activity in serum. In Terasaki, P., ed., Histocompatibility Testing, p. 483. Munksgaard, Copenhagen.
11. Pellegrino, M. A., Indiven, F., Fagiolo, U., Antonello, A. and Ferrone, S. 1982. Immunogenicity of serum HLA antigens in allogenic combinations. Transplantation 33:530.
12. Hausmann, R., Zavazava, N., Steinmann, J. and Müller-Ruchholtz, W, 1993. Interaction of papain-digested HLA class I molecules with human alloreactive cytotoxic T lymphocytes (CTL). Clin. Exp. Immunol. 91:183.
13. 2 domain of HLA-A2. Nature 325:625.
14. Puppo, F., Brenci, S., Montinaro, E., Lanza, L., Contini, P., Scudeletti, M. and Indiveri, F. 1994. Inhibition of alloreactive cytotoxic T cell activity by HIV-positive sera: potential role of circulating soluble HLA class I molecules. AIDS Res. Hum. Retroviruses 10:1061.
15. Dal Porto, J., Johansen, T, E., Catipovic, B., Parfiit, D. J., Tuveson, D., Gether, U., Kozlowski, S., Fearon, D. T. and Schneck, J. P. 1993. A soluble divalent class I major histocompatibility complex molecule inhibits alloreactive T cells at nanomolar concentrations. Proc. Natl Acad. Sci. USA 90:6671.
16. Zavazava, N. and Krönke, M. 1996. Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes. Nat. Med. 2:1005.
17. Barnstable, C. J., Bodmer, W. F., Brown, G., Galfre, G., Milstein, C., Williams, A. F. and Ziegler, A. Z. 1978. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens: new tools for genetic analysis. Cell 14:9.
18. D'Urso, C. M., Wang, Z. G., Cao, Y., Tatake, R., Zeff, R. A. and Ferrone, S. 1991. Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression.J. Clin. Invest. 87:284.
19. Stam, N. J., Spits, H. and Ploegh. H. L. 1986. Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products. J. Immunol. 137:2299.
20. Pellegrino, M. A., Ng, A. K., Russo, C. and Ferrone, S. 1982. Heterogeneous distribution of determinants defined by monoclonal antibodies on HLA-A and B antigens bearing molecules. Transplantation 34:18.
21. Temponi, M., Kekish, U., Hamby, C. V., Nielsen, H., Marboe, C. C. and Ferrone, S. 1993. Characterization of anti-HLA class II monoclonal antibody LGII-612, 14 reacting with formalin fixed tissues. J. Immunol. Methods 161:239.
22. Tanaka, M., Suda, T., Haze, K., Nakamura, N., Sato, K., Kimura, F., Motoyoshi, K., Mizuki, M., Tagawa, S., Ohga, S., Hatake, K., Drummond, A. H. and Nagata, S. 1996. Fas ligand in human serum. Nat. Med. 2:317.
23. Russo, C., Callegaro, L., Lanza, E. and Ferrone, S. 1983. Purification of IgG monoclonal antibody by caprilic acid precipitation. J. Immunol. Methods 65:269.
24. 3 domain. J. Immunol. 148:3202.
25. Coligan, J. E. et al., eds. 1998. Current Protocols in Immunology, vol. 3, p, 18.3. John Wiley, New York.
26. Böyum, A. 1968. Separation of leukocytes from blood and bone marrow. Scand. J. Clin. Lab. Invest. 21 (Suppl. 97):77.
27. Joyce, S., Tabaczewski, P., Angeletti, R. H., Nathenson, S. G. and Strojnowski, I. 1994. A non-polymorphic major histocompatibility complex class Ib molecule binds a large array of diverse cells-peptides. J. Exp. Med. 179:579.
28. Filaci, G., Contini, P., Brenci, S., Lanza, L., Scudeletti, M., Indiveri, F. and Puppo, F. 1995. Increased serum concentration of soluble HLA-DR antigens in HIV infection and following transplantation. Tissue Antigens 46:117.
29. Russo, C., Pellegrino, M. A. and Ferrone, S. 1983. A double-determinant immunoassay with monoclonal antibodies to the HLA-A. B, C complex. Transplant. Proc. 15:66.
30. Nicoletti, I., Migliorati, G., Pagliacci, M. C., Grignani, F. and Riccardi, C. 1991. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 139:271.
31. Coligan, J. E. et al., eds. 1998. Current Protocols in Immunology, vol. 2, p, 10.4. John Wiley, New York.
32. Grossi, C. E., Webb, S. R., Zicca, A., Lydyard, P. M., Moretta, L., Mingari, M. C. and Cooper, M. D. 1978. Morphological and histochemical analyses of two human T-cell subpopulations bearing receptors for IgM or IgG. J. Exp. Med. 147:1405.
33. + T cell population. Eur. J. Immunol. 25:2907.
34. + T cells via Fas-Fas ligand-mediated apoptosis. J. Immunol. 158:1503.
35. Dobbe, L. M. E., Stam, N. J., Neefjes, J. J. and Giphart, M. J. 1988. Biochemical complexity of serum HLA class I molecules. Immunogenetics 27:203.
36. Tanaka, M., Suda, T., Takahashi, T. and Nagata, S. 1995. Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J. 14:1129.
37. Yewdell, J. W. and Bennink, J. R. 1992. Cell biology of antigen processing and presentation to major histocompatibility complex class I molecule-restricted T lymphocytes. Adv. Immunol. 52:1.
38. 3 domain of HLA-A2. Nature 345:41.
39. Fajen, J., Huang, J. H., Meyerson, H., Zhang, D., Getty, R., Greenspan, N. and Tykocinski, M. 1995. Class I MHC alpha 3 domain can function as an independent structural unit to bind CD8 alpha. Mol. Immunol. 32:275.
40. Norment, A. M., Salter, R. D., Parham. P., Engelhard, V. H. and Littman, D. R. 1988. Cell-cell adhesion mediated by CD8 and MHC class I molecules. Nature 336:79.
41. Sun, J., Leahy, D. J. and Kavathas, P. B. 1995. Interaction between CD8 and major histocompatibility complex (MHC) class I mediated by multiple contact surfaces that include the α2 and α3 domains of MHC class I. J. Exp. Med. 182:1275.
42. Gao, G. F., Tormo, J., Gerth, U. C., Wyer, J. R., McMichael, A. J., Stuart, D.I., Bell, J. I., Jones, E. Y. and Jakobsen, B. K. 1997. Crystal structure of the complex between human CD8 alpha (alpha) and HLA-A2. Nature 387:630.
43. Julius, M., Maroun, C. R. and Haughn, L. 1993. Distinct roles for CD4 and CD8 as co-receptors in antigen receptor signalling, Immunol. Today 14:177.
44. O'Rourke, A. M. and Mescher, M. F. 1993. The roles of CD8 in cytotoxic T lymphocyte function, Immunol. Today 14:183.
45. lck. Cell 55:301.
46. Parnes, J. R. 1989. Molecular biology and function of CD4 and CD8. Adv. Immunol. 44:265.
47. Choksi, S., Jameson, B. A. and Korngold, R. 1998. A structure-based approach to designing synthetic CD8 a peptides that can inhibit cytotoxic T-lymphocyte responses. Nat. Med. 4:309.
48. Miceli, M. C., von Hoegen, P. and Parnes, J. R. 1991. Adhesion versus coreceptor function of CD4 and CD8: role of the cytoplasmic tail in coreceptor activity. Proc. Natl Acad. Sd. USA 88:2623.
49. Miceli, M. C. and Parnes, J. R. 1993. Role of CD4 and CD8 in T cell activation and differentiation. Adv. Immunol. 53:59.
50. Eischen, C. M., Williams, B. L., Zhang, W., Samelson, L. E., Lynch, D. H., Abraham, R. T. and Leibson, P. J. 1997. ZAP-70 tyrosine kinase is required for the up-regulation of Fas ligand in activation-induced T cell apoptosis. J. Immunol. 159:1135.
51. Nagata, S. 1994. Fas and Fas ligand : a death factor and its receptor. Adv. Immunol. 57:129.
52. + T cells. Proc. Natl Acad. Sci. USA 93:11014.
53. Esser, M. I., Krishnamurthy, B. and Braciale, V. L. 1996. Distinct T cell receptor signaling requirements for perforin- or FasL-mediated cytotoxicity. J. Exp. Med. 183:1697.
54. Walsh, C., Glass, A., Chiu, V, and Clark W. 1994. The role of the Fas lytic pathway in a perforin-less CTL hybridoma. J. Immunol. 153:2506.
55. Kagi, D., Vignaux, F., Ledermann, B., Burki, K., Depraetere, V., Nagata, S., Hengartner, H. and Golstein, R 1994. Fas and perforin pathways as major mechanisms of T cell mediated cytotoxicity. Science 265:528.
56. Lowin, B., Hahne, M., Mattmenn, C. and Tschopp, J. 1994 Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 370:650.
57. Mountz, J. D., Zhou, T., Wu, J., Wang, W., Su, X. and Cheng J. 1995. Regulation of apoptosis in immune cells. J. Clin, Immunol. 15:1.
58. van Parijs, L. and Abbas, A. K. 1996. Role of Fas-mediated cell death in the regulation of immune responses Curr. Opin. Immunol. 8:355.
59. Yonehara, S., Nishimura, Y., Kishil, S., Yonehara, M., Takazawa, K., Tamatani, T. and Ishii, A. 1994. Involvement of apoptosis antigen Fas in clonal deletion of human thymocytes. Int. Immunol. 6:1849.
60. Lynch, D. H., Ramsdell, F. and Alderson, M. R. 1995. Fas and FasL in the homeostatic regulation of immune responses, Immunol. Today 16:569.
61. Kabelitz, D., Oberg, H.H., Pohl, T. and Pechhold, K. 1994. Antigen-induced death of mature T lymphocytes: analysis by flow cytometry. Immunol Rev. 142:157.
62. + T cells induced by cross-presentation of self-antigens involves signaling through CD95 (Fas, Apo-1). J. Exp. Med. 188:415.
63. + T cells are markers for HIV1 infection and clinical status. J. Clin. Immunol. 17:185.
64. Kanda, Y., Tanaka, Y., Shirakawa, K., Yatomi, T., Nakamura, N., Kami, M., Saito, T., Izutsu, K., Asai, T., YuJi, K., Ogawa, S., Honda, H., Mitani, K., Chiba, S., Yazaki, Y. and Hirai, H. 1998. Increased soluble Fas-ligand in sera of bone marrow transplant recipients with acute graft-verus-host disease. Bone Marrow Transplant. 22:735.
65. Ghio, M., Contini, P., Mazzei, C., Brenci, S., Barberis, G., Filaci, G., Indiveri, F. and Puppo, F. 1999. Soluble HLA class I, HLA class II and Fas Ligand in blood components: a possible key to explain the immunomodulatory effect of allogeneic blood transfusions. Blood 93:1770.
66. + patients. Am. J. Pathol. 146:1542.
67. Jollow, K. C., Sundstrom, J. B., Gravanis, M. B., Kanter, K., Herskowitz, A. and Ansaari, A. A. 1997. Apoptosis of mononuclear cell infiltrates in cardiac allograft biopsy specimens questions studies of biopsy cultured cells. Transplantation 63:1482.
68. Meehan, S. M., McCluskey, R. T., Pascual, M., Preffer, F. I., Anderson, P., Schlossman, S. F. and Colvin, R. B. 1997.Cytotoxicity and apoptosis in human renal allografts: identification, distribution, and quantitation of cells with a cytotoxic granule protein GMP 17 (TIA 1) and cells with fragmented nuclear DNA. Lab. Invest. 76:639.